Within the scope of the Volatility Based Measures System (VBMS) that is being implemented in accordance with the Capital Markets Board's decisions, CEOEM.E and SURGY.E shares will be subject to prohibition of margn trading measure from 18/11/2024 (beginning of the session) until 17/12/2024 (end of the session).

Note: Measures implemented within the scope of the VBMS are considered separately from trading principles applied for the share as a result of the trading rules of the market/platform in which the share is traded, market segment changes, or other reasons. Accordingly, measures taken with respect to VBMS continue to be implemented until the end of the measure's implementation period irrespective of the validity period of the trading principles implemented with other regulations or decisions.